The Production Alliance is set up to provide customers with a broader range of contract services, offering access to BI’s high expression BI HEX technology, Avid's process development and cGMP manufacturing, along with access to BI’s large-scale commercial manufacturing facilities. The two companies have compatible technology platforms that support a flexible approach in order to facilitate seamless technology transfers throughout the development, scale-up, clinical and commercial scale production phases.
"With its location on the West Coast of the U.S. and a reputation for quality and innovation, Avid Bioservices is well positioned to play an important role as a strategic partner in our global Production Alliance Network," said Professor Dr. Rolf G. Werner, senior vice president of Boehringer Ingelheim's Corporate Division Biopharmaceuticals. "The Network complements our worldwide strategic manufacturing capabilities with strong regional partners providing process development and clinical supply manufacturing capacity and expertise. We believe this partnership benefits both our partners and our customers, and we look forward to working with the Avid team."
"With this agreement, Avid joins an elite group of Boehringer Ingelheim strategic biologics manufacturing partners located in biotech clusters around the world," said Christopher Eso, vice president of business operations of Avid Bioservices. "This agreement represents an important element of Avid's overall growth strategy and is a testament to the quality of services the Avid team provides to its clients. We expect it will extend both companies' customer offerings by capitalizing on the distinctive capabilities of each."